Robert (Rob) Kossmann is executive vice president and chief medical officer for Care Enablement, Fresenius Medical Care. From 2019 to 2021, he served as executive vice president and chief medical officer for Fresenius Medical Care North America. From 2014 to 2019, he was chief medical officer for Fresenius Medical Care’s Renal Therapies Group, the company’s medical equipment and renal pharmaceuticals division. Dr. Kossmann has been active in helping guide the nephrology field through leadership roles, including as former president of the Renal Physicians Association (RPA); a founding member of RPA’s Nephrology Coverage Advocacy Program (now Policy Advocacy Leadership program); a nephrology advisor to the American Medical Association’s Relative Value Scale Update Committee; and founder of the New Mexico Renal Disease Collaborative Group. A practicing nephrologist for two decades, Dr. Kossmann trained in nephrology at the University of Washington in Seattle and holds his bachelor’s and Doctor of Medicine degrees from Case Western Reserve University in Cleveland, Ohio.